Título:
|
Evaluating the care cascade after antiretroviral therapy initiation in Latin America
|
Autores:
|
Wolff, M. J. ;
Cortes, C. P. ;
Mejía, F. A. ;
Padgett, D. ;
Belaunzarán-Zamudio, P. ;
Grinsztejn, B. ;
Giganti, M. J. ;
McGowan, C. C. ;
Rebeiro, P. F.
|
Tipo de documento:
|
texto impreso
|
Editorial:
|
SAGE and Open Access, 2018-03-22T23:38:49Z
|
Nota general:
|
info:eu-repo/semantics/restrictedAccess
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
|
Idiomas:
|
Inglés
|
Palabras clave:
|
Editados por otras instituciones
,
Artículos
,
Artículos en revistas indizadas
|
Resumen:
|
Accelerating antiretroviral therapy (ART) administration, improving retention, and achieving viral suppression in low- and middle-income countries must be prioritized. We evaluated trends and disparities in these milestones in a large Latin American cohort. Adults starting ART (ARTstart) from 2003 to 2014 at Caribbean, Central, and South America network for HIV epidemiology sites were assessed for care cascade outcomes: CD4 cell count >200 cells/mm3 at ARTstart; retention (?1 visit at one year after ARTstart); viral suppression (?1 HIV-1 RNA 200 cells/mm3. Females and men who have sex with men (MSM) were more likely to have CD4 cell count >200 cells/mm3 at ARTstart. Injection drug users (IDUs) were less likely to be retained while MSM were more likely to achieve viral suppression (all p
|
En línea:
|
https://doi.org/10.1177/0956462417714094
|